Identification of frequent G2 checkpoint impairment and a homozygous deletion of 14-3-3ε at 17p13.3 in small cell lung cancers

Cancer Research

Volumn 62, Issue 1, 2002, Pages 271-276

  Konishi, Hiroyuki ^a,b   Nakagawa, Taku ^a   Harano, Tomoko ^a   Mizuno, Kotaro ^a   Saito, Hiroko ^a   Masuda, Akira ^a   Osada, Hirotaka ^a   Takahashi, Takashi ^a   Matsuda, Hikaru ^b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE G2 PHASE; CHROMOSOME 17P; DNA DAMAGE; GENE DELETION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; METASTASIS; MITOSIS; PRIORITY JOURNAL; X IRRADIATION;

14-3-3 PROTEINS; CARCINOMA, SMALL CELL; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 17; G2 PHASE; GENE DELETION; HUMANS; LUNG NEOPLASMS; MITOSIS; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE;

EID: 0036141604     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Cancer of the lung
2. Cell biology and molecular biology of small cell and non-small cell lung cancer
3. p53: A frequent target for genetic abnormalities in lung cancer
4. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers
5. Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers
6. Topographical distributions of allelic loss in individual non-small-cell lung cancers
7. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis
8. Allelic deletion on chromosome 17p13.3 in early ovarian cancer
9. Identification of two candidate tumor suppressor genes on chromosome 17p13.3
10. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3
11. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers
12. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers
13. High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
14. Inactivation of the 14-3-3 σ gene is associated with 5′ CpG island hypermethylation in human cancers
15. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis
16. DNA double-strand breaks: Signaling, repair and the cancer connection
17. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein
18. DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding
19. 2 arrest in the Xenopus oocyte: A role for 14-3-3-mediated inhibition of Cdc25 nuclear import
20. Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25
21. Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site
22. Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding
23. 14-3-3 Proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts
24. Two novel cell surface antigens on small cell lung carcinoma defined by mouse monoclonal antibodies NE-25 and PE-35
25. Glutathione S-transferase π levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity
26. Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor β1
27. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes
28. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern
29. Persistent increase in chromosomal instability in lung cancer: Possible indirect involvement of p53 inactivation
30. 2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6
31. Spontaneous premature chromosome condensation and mitotic catastrophe following irradiation of HeLa S3 cells
32. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
33. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
34. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
35. A cell cycle regulator potentially involved in genesis of many tumor types
36. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers
37. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
38. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
39. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
40. Pten, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
41. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multip]e advanced cancers
42. 14-3-3σ Is required to prevent mitotic catastrophe after DNA damage
43. Inactivation of 14-3-3σ influences telomere behavior and ionizing radiation-induced chromosomal instability
44. Nuclear localization of cyclin B1 controls mitotic entry, after DNA damage
45. Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase
46. 2 arrest after DNA damage
47. 2 checkpoint is maintained by redundant pathways
48. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation
49. Frequent hyperrnethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma
50. Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer
51. Reduced expression and impaired kinase activity of a Chk2 mutant identified in human lung cancer